Evidence map›Paper›PMID 34858761›Full record

ReviewCureus2021

Pathophysiology and Clinical Implications of Cognitive Dysfunction in Fibromyalgia.

Weaam Ibraheem, Simon Mckenzie, Victory Wilcox-Omubo, Mohamed Abdelaty, Sandra E Saji, Rosemary Siby, Wafaa Alalyani, Jihan A Mostafa

Open access · diamondAbstract readReview
In one paragraph

Review in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Article
  3. Cognitive profiling in fibromyalgia patients using the MoCA.Irish journal of medical science · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Weaam IbraheemMedical Research, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Simon MckenzieMedical Research, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Victory Wilcox-OmuboMedical Research, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Mohamed AbdelatyMedical Research, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Sandra E SajiMedical Research, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Rosemary SibyMedical Research, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Wafaa AlalyaniMedical Research, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Jihan A MostafaPsychiatry, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
California Institute of Behavioral Neurosciences and Psychology (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cognitive dysfunction is a complaint of many patients diagnosed with fibromyalgia. Although the main symptoms of the disease are fatigue, widespread musculoskeletal pain, poor sleep quality, and tenderness points, the cognitive symptoms can be more distressing than the pain itself, and negatively affect their lives; however, many healthcare professionals underestimate these cognitive complaints and it is still one of the least researched topics. Proper management of these symptoms at an early stage may have a great impact to improve the mental health, physical function, and overall health of these patients. Hence, this traditional review aimed to look at the previous body of literature in PubMed in the past five years to address the pathophysiology of the cognitive dysfunction in fibromyalgia patients, to find the risk factors of cognitive dysfunction in these patients, to discover the recent modalities for treatment, and to figure out the clinical implications and recent recommendations by researchers on screening, diagnosis, and management of fibromyalgia and its cognitive dysfunction symptoms. This review has shown the various mechanisms of cognitive dysfunction. Some mechanisms are related to disease symptomologies, such as excessive pain perception, and others are related to hormonal and metabolite changes in the brain. Tobacco smoking and high body mass index showed an inverse impact on cognitive dysfunction and quality of life in fibromyalgia. Other risk factors and clinical implications were discussed in detail.

Indexed as

cognitive dysfunctionfibro-fogfibromyalgiapathophysiologyrisk factors

Identifiers

PMID34858761
PMCPMC8614169
OpenAlexW3208571701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.